- Home
- HOUS vs PCRX Comparison
HOUS vs PCRX Comparison
Compare HOUS & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUS
- PCRX
- Stock Information
- Founded
- HOUS 2006
- PCRX 2006
- Country
- HOUS United States
- PCRX United States
- Employees
- HOUS N/A
- PCRX N/A
- Industry
- HOUS Real Estate
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- HOUS Finance
- PCRX Health Care
- Exchange
- HOUS Nasdaq
- PCRX Nasdaq
- Market Cap
- HOUS 1.1B
- PCRX 1.2B
- IPO Year
- HOUS 2006
- PCRX 2011
- Fundamental
- Price
- HOUS $11.50
- PCRX $21.97
- Analyst Decision
- HOUS Hold
- PCRX Strong Buy
- Analyst Count
- HOUS 3
- PCRX 5
- Target Price
- HOUS $8.50
- PCRX $33.00
- AVG Volume (30 Days)
- HOUS 2.8M
- PCRX 696.0K
- Earning Date
- HOUS 11-04-2025
- PCRX 11-06-2025
- Dividend Yield
- HOUS N/A
- PCRX N/A
- EPS Growth
- HOUS N/A
- PCRX N/A
- EPS
- HOUS N/A
- PCRX 0.47
- Revenue
- HOUS $5,874,000,000.00
- PCRX $716,791,000.00
- Revenue This Year
- HOUS $6.18
- PCRX $7.27
- Revenue Next Year
- HOUS $6.52
- PCRX $10.18
- P/E Ratio
- HOUS N/A
- PCRX $46.78
- Revenue Growth
- HOUS 5.27
- PCRX 3.14
- 52 Week Low
- HOUS $2.71
- PCRX $16.00
- 52 Week High
- HOUS $12.03
- PCRX $27.64
- Technical
- Relative Strength Index (RSI)
- HOUS 69.48
- PCRX 44.53
- Support Level
- HOUS $9.60
- PCRX $21.20
- Resistance Level
- HOUS $11.75
- PCRX $22.70
- Average True Range (ATR)
- HOUS 0.52
- PCRX 1.25
- MACD
- HOUS 0.04
- PCRX 0.13
- Stochastic Oscillator
- HOUS 88.17
- PCRX 51.44
About HOUS Anywhere Real Estate Inc.
Anywhere Real Estate Inc operates in residential real estate, focusing on brokerage, relocation, title, settlement businesses, and mortgage and title insurance ventures. It supports approximately 1 million home sale sides annually. Brands include Better Homes and Gardens, CENTURY 21, Coldwell Banker, Corcoran, ERA, and Sotheby's International Realty. Revenue comes mainly from existing home transactions. Operations are segmented into Anywhere Brands (franchises), Anywhere Advisors (owned brokerage), and Anywhere Integrated Services (title and settlement).
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.